DOP2006000268A - Agentes antibacterianos - Google Patents

Agentes antibacterianos

Info

Publication number
DOP2006000268A
DOP2006000268A DO2006000268A DO2006000268A DOP2006000268A DO P2006000268 A DOP2006000268 A DO P2006000268A DO 2006000268 A DO2006000268 A DO 2006000268A DO 2006000268 A DO2006000268 A DO 2006000268A DO P2006000268 A DOP2006000268 A DO P2006000268A
Authority
DO
Dominican Republic
Prior art keywords
compounds
antibacterial agents
methods
antibacterial
preparing
Prior art date
Application number
DO2006000268A
Other languages
English (en)
Spanish (es)
Inventor
Timothy Allen Johnson
Debra Ann Sherry
Dennis Joseph Mcnamara
Peter Laurence Toogood
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37872452&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DOP2006000268(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of DOP2006000268A publication Critical patent/DOP2006000268A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
DO2006000268A 2005-12-22 2006-11-29 Agentes antibacterianos DOP2006000268A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75326205P 2005-12-22 2005-12-22

Publications (1)

Publication Number Publication Date
DOP2006000268A true DOP2006000268A (es) 2007-07-31

Family

ID=37872452

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2006000268A DOP2006000268A (es) 2005-12-22 2006-11-29 Agentes antibacterianos

Country Status (12)

Country Link
US (2) US7557100B2 (enExample)
EP (2) EP2620439A1 (enExample)
JP (1) JP5513743B2 (enExample)
AR (1) AR058701A1 (enExample)
CA (1) CA2634644A1 (enExample)
DO (1) DOP2006000268A (enExample)
GT (1) GT200600520A (enExample)
NL (1) NL2000373C2 (enExample)
PE (1) PE20071137A1 (enExample)
TW (1) TW200734344A (enExample)
UY (1) UY30030A1 (enExample)
WO (1) WO2007072151A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601695B2 (en) 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
DOP2006000268A (es) * 2005-12-22 2007-07-31 Pfizer Prod Inc Agentes antibacterianos
RU2010103101A (ru) * 2007-07-02 2011-08-10 Астразенека Аб (Se) Химические соединения
ATE523592T1 (de) * 2007-07-06 2011-09-15 Univ Aarhus Dehydratisierte chitosan-nanopartikel
US20110178064A1 (en) 2007-07-16 2011-07-21 Astrazeneca R&D Spiro condensed barbituric acid derivatives for use as antibacterial
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
US9040528B2 (en) 2008-10-14 2015-05-26 Astrazeneca Ab Chemical compounds 542
TW201020258A (en) * 2008-10-14 2010-06-01 Astrazeneca Ab Chemical compounds 542
CN107854477A (zh) 2008-10-24 2018-03-30 森普拉制药公司 使用含三唑的大环内酯治疗抗性疾病的方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
HRP20160168T1 (hr) 2010-03-22 2016-03-25 Cempra Pharmaceuticals Inc Kristalne forme makrolida i njihova uporaba
BR112012029586A2 (pt) 2010-05-20 2016-08-02 Cempra Pharmaceuticals Inc processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
WO2013148891A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
US8952149B2 (en) 2012-09-26 2015-02-10 Zoetis Llc Tricyclic tetrahydroquinoline antibacterial agents
US8889671B2 (en) 2013-01-23 2014-11-18 Astrazeneca Ab Compounds and methods for treating bacterial infections
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
AU2014233240B2 (en) 2013-03-15 2018-08-09 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
SG11201609404SA (en) 2014-05-29 2016-12-29 Entasis Therapeutics Ltd Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
IL317854A (en) 2017-07-28 2025-02-01 Takeda Pharmaceuticals Co TYK2 inhibitors and their uses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011860A (en) * 1986-04-11 1991-04-30 Schering Corporation Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases
DE19502178A1 (de) * 1994-01-27 1995-08-03 Hoechst Ag Thiadiazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Vorprodukte zur Herstellung von Flüssigkristallen
US6608081B2 (en) * 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
CZ20031083A3 (cs) 2000-10-26 2004-03-17 Pfizer Products Inc. 5-Spiropyrimidin-2, 4, 6-trionové inhibitory metaloproteinasy
BR0210099A (pt) * 2001-05-30 2004-04-13 Warner Lambert Co Agentes antibacterianos
AU2003228701A1 (en) 2002-04-25 2003-11-10 Bristol-Myers Squibb Company Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteases
US7208490B2 (en) 2002-10-07 2007-04-24 Pharmacia & Upjohn Company Llc Tricyclic tetrahydroquinoline antibacterial agents
CA2606847A1 (en) 2005-05-09 2006-11-16 Warner-Lambert Company Llc Antibacterial agents
DOP2006000268A (es) * 2005-12-22 2007-07-31 Pfizer Prod Inc Agentes antibacterianos

Also Published As

Publication number Publication date
WO2007072151A1 (en) 2007-06-28
UY30030A1 (es) 2007-07-31
JP5513743B2 (ja) 2014-06-04
JP2009520804A (ja) 2009-05-28
US20090275536A1 (en) 2009-11-05
NL2000373A1 (nl) 2007-06-26
AR058701A1 (es) 2008-02-20
TW200734344A (en) 2007-09-16
CA2634644A1 (en) 2007-06-28
US7557100B2 (en) 2009-07-07
NL2000373C2 (nl) 2010-02-02
US20070197518A1 (en) 2007-08-23
GT200600520A (es) 2007-07-17
EP1971612A1 (en) 2008-09-24
EP2620439A1 (en) 2013-07-31
PE20071137A1 (es) 2008-01-10

Similar Documents

Publication Publication Date Title
GT200600520A (es) Agentes antibacterianos
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
UY30759A1 (es) Compuestos quimicos
BRPI0810064B8 (pt) compostos contendo nitrogênio tricíclico como agentes antibacterianos, composições farmacêuticas que compreendem os ditos compostos e uso dos mesmos para o tratamento de infecções bacterianas em mamíferos
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
CO6321189A2 (es) Compuestos de tiazol y oxazol de bencen-sulfonamida
NO20082191L (no) Forbindelser
CL2007002100A1 (es) Compuestos derivados biciclicos que contienen nitrogeno, sus sales, solvatos y n-oxidos; composicion farmaceutica; y uso para el tratamiento de infecciones bacterianas.
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
UY32158A (es) Derivados heterociclicos y metodos de uso de los mismos
EA200901617A1 (ru) Борсодержащие молекулы небольшого размера
CL2011000691A1 (es) Compuestos derivados de nicotinamida sustituida; composicion farmaceutica que los comprende; uso para el tratamiento y/o prevencion de cancer, infecciones, enfermedades inflamatorias y autoinmunitarias.
CL2008002430A1 (es) Compuestos derivados de bencenosulfonamida, inhibidores de catepsina c; composicion farmaceutica que los comprende; y su uso para el tratamiento de la epoc.
BRPI0815920A2 (pt) Composto, composição farmacêutica, e, uso do composto.
DE602004021644D1 (de) Gyraseinhibitoren und deren verwendungen
PA8855001A1 (es) Monocarbamas
GT201000047A (es) Mejoras en compuestos organicos o relacionadas con los mismos
UY30544A1 (es) Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones
CL2008000202A1 (es) Compuestos derivados de n-aril-acetamida, antagonista trpv1;composicion farmaceutica que los comprende, utiles en el tratamiento del dolor.
UY29767A1 (es) Derivados de benzotiazolonas, procesos para su preparación, composiciones farmacéuticas que los contienen y aplicaciones
UY31864A (es) Derivados de urea hetericíclica y métodos de uso de los mismos-332
CL2007001542A1 (es) Compuestos derivados de aminotiazoles, composicion farmaceutica; y uso para el tratamiento de infecciones bacterianas.
CL2008001990A1 (es) Compuestos derivados de amino-quinazolinas sustituidas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de alzheimer.
NO20062705L (no) Antimikrobiell sammensetning anvendbar for impregnering av treverk
DE602006012694D1 (de) Benzimidazolthiophenverbindungen als plk-modulatoren